Lieberman and Duffield receive Indiana CTSI 2011 Fall Core Pilot Grants

Author: Indiana CTSI

indiana clinical and translational science institute logo

The Indiana Clinical and Translational Science Institute has announced the recipients of its biannual program to provide small grants to investigators whose project will benefit from to access cutting-edge scientific expertise and technology. Two of the faculty are from the College of Science. Giles Duffield, assistant professor of biological sciences, and Marya Lieberman, associate professor of chemistry and biochemistry, have received awards.

The 2011 Fall Core Pilot Grant Program provides nearly $170,000 to 19 researchers at Indiana University, Purdue University and the University of Notre Dame. Lab technologies available to recipients will range from biological microscopy to mass spectrometry and proteomics analysis, all provided by Indiana CTSI-designated cores — laboratories whose operations have been reviewed and approved by the Indiana CTSI.

Giles Duffield, assistant professor of biological sciences, will receive $10,000 to support a project titled “Circadian programming of the Anopheles gambiae malaria mosquito: time-of-day specific profiling of olfaction and metabolic detoxification proteins.” Core services will be provided by Notre Dame’s Mass Spectrometry and Proteomics Facility, directed by William Boggess Jr.

Marya Lieberman, associate professor of chemistry and biochemistry, will receive $8,730 to support a project titled, “Validation of paper analytical devices for beta lactam antibiotics and antimalarial combination therapy drugs.” Core services will be provided by Notre Dame’s Mass Spectrometry and Proteomics Facility.

“This program aims to enhance the research at IU, Purdue and Notre Dame by encouraging investigators to include the latest molecular technologies in their work,” says Kenneth Cornetta, MD, director of the Indiana CTSI Translational Technologies and Resources Program and chair and Joe C. Christian Professor of Medical and Molecular Genetics at the IU School of Medicine. “A small, strategic investment that expands the scope of a research project can make the difference between a successful and unsuccessful federal grant application. This program gives researchers the boost they need to reach the next level.”

The program’s specific goal is to fund projects with “outstanding scientific merit and potential to generate extramural funding or novel intellectual property.” Awards are given only to research that directly utilizes the CTSI core facilities within 24 months of the grant.

For more information on translational technologies and resources supported by the Indiana CTSI, visit www.indianactsi.org/servicecores.